Skip to content
  • About Us
    • Careers
  • Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q1 2021

  • June 28, 2021
  • Industry Updates
  • Healthcare, Medical Technology
2021: Hope On The Horizon
  • For millions of Americans and others around the world who have received a COVID-19 vaccine, reassuring signs of hope have begun to emerge. As of the time of publication, just under half of Americans have received at least one dose, with over 44% fully vaccinated. A rollout of this speed is monumental, with over 300 million doses administered to date.
  • This effort was enabled by partnerships between the public and private sector, with healthcare companies of all types playing a role. The rollout of the vaccine in the U.S. was largely successful, with doses administered skyrocketing during February, March, and April, with the percentage of Americans who received at least one dose climbing from 7.9% February 1, to 44.1% by April 30. Recently however, vaccinations have plateaued in some areas, and these pockets are seeing rising COVID cases. Nevertheless, the rapid development and rollout of COVID-19 should be considered one of the most impactful public health achievements in decades, with innumerable lives saved and the potential for life to return to normalcy now conceivable.
  • During the year to date, PMCF’s four Medical Technology indices have generally followed the performance trends of the benchmark S&P 500 Growth Index and Dow Jones Industrial Average, though they lagged behind the Dow’s robust performance during March and April.

 

Read Medical Technology M&A Pulse Q1 2021 Full Report
Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Plastics M&A Update – November 2022
Packaging M&A Update – November 2022
Industrial Distributor M&A Pulse – Q3 2022
Food & Beverage M&A Pulse – Q3 2022
Plastics M&A Update – October 2022
Contact

Follow Us On

Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

PMCF is a trade name for PMCF Advisors, LLC and P&M Corporate Finance, LLC. The term “PMCF” refers to one or more of these legally separate and independent advisory practices. P&M Corporate Finance, LLC provides capital raising and private placement services that require registration as a broker-dealer.

©2022 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​